Aceso acquisition of 58.92 per cent stake in HealthCare Global approved by CCI

Published On 2020-07-17 05:00 GMT   |   Update On 2021-11-22 17:20 GMT

New Delhi: The Competition Commission on Wednesday said it has given its nod to Aceso Company Pte Ltd's acquisition of 58.92 per cent stake in HealthCare Global Enterprises Ltd. According to the combination notice filed with the regulator, the proposed transaction involves investment by Aceso by way of subscription to equity shares and warrants representing the right to subscribe to the...

Login or Register to read the full article

New Delhi: The Competition Commission on Wednesday said it has given its nod to Aceso Company Pte Ltd's acquisition of 58.92 per cent stake in HealthCare Global Enterprises Ltd.

According to the combination notice filed with the regulator, the proposed transaction involves investment by Aceso by way of subscription to equity shares and warrants representing the right to subscribe to the equity shares of HealthCare Global.

In a tweet, the Competition Commission of India (CCI) said it "approves acquisition of upto 58.92% stake of HealthCare Global Enterprises Limited by Aceso Company Pte. Ltd."

HealthCare Global Enterprises and its group are engaged in providing services through cancer treatment clinics, multispecialty hospitals, fertility treatment centres, apart from others, while Aceso Company forms a part of the CVC Network, the notice noted.

The CVC Network consists of CVC Capital Partners SICAV-FIS S.A. and its subsidiaries, and CVC Capital Partners Advisory Group Holding Foundation and its subsidiaries, which are privately owned entities whose activities include providing investment advice and managing investments on behalf of certain investment funds and platforms, it added.

Read also: Merck division Acquires US Rights to SENTINEL Brand of Combination Parasiticides for Companion Animals


Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News